Furthermore, new evidence suggested that Linc00284 was involved in the progression of gastric cancer [11], primary papillary thyroid carcinoma [12], breast cancer [13], and hepatocellular carcinoma [14]. This evidence concerns the gene NRAD1 and thyroid gland papillary carcinoma.